Patil Rajkumar V. — SEC Form 4 filings
SEC reporting owner CIK 2124067. 2 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2026-07-29 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 3,363 shares, $5,011 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 3,363 shares @ $1.49 ($5,011) in OKYO Pharma Ltd, filed 2026-08-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OKYO Pharma Ltd (OKYO) | Chief Scientific Officer | 2 | 1 leg · 3,363 sh · $5,011 | — | 1 |
Form 4 filings — Patil Rajkumar V.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4/A | OKYO Pharma Ltd (OKYO) | Purchase (P): 3,363 @ $1.49 | EDGAR |
| 2026-07-29 | 4 | OKYO Pharma Ltd (OKYO) | Grant/award (A): 3,363 @ $1.49 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2124067 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →